文献速递造血干细胞移植与细胞治疗白血病

白消安、氟达拉滨和抗胸腺细胞球蛋白统一预处理方案用于单倍体家族供者、同胞全合供者或无关供者异基因造血细胞移植——一项单中心、前瞻性、探索性研究

A uniform conditioning regimen of busulfan, fludarabine, and antithymocyte globulin for allogeneic haematopoietic cell transplantation from haploidentical family, matched sibling, or unrelated donors-A single-centre, prospective, explorative study.
PubMed 文献 · Br J Haematol · 2022-11-12

该前瞻性探索性研究纳入101例完全缓解的急性髓系白血病患者,采用含抗胸腺细胞球蛋白的统一预处理方案,比较单倍体家族供者、同胞全合供者与无关供者移植的结局。单倍体家族移植的急性移植物抗宿主病累积发生率显著更高(49% vs 7% vs 16%,p<0.001),且移植后1个月外周血单个核细胞完全供者嵌合比例更高(88% vs 46% vs 69%,p=0.001),而植入、慢性移植物抗宿主病、白血病复发、非复发死亡及患者生存无显著差异。

要点

  • 单倍体家族移植急性GVHD累积发生率49%,高于同胞全合7%和无关供者16%(p<0.001)。
  • 单倍体家族移植中约四分之一急性GVHD发生于植入后3天内,表现为弥漫性皮疹、发热、体重增加和低白蛋白血症。
  • 移植后1个月外周血单个核细胞完全供者嵌合比例单倍体家族88%、同胞全合46%、无关供者69%(p=0.001)。

核心结论

  • 在接受含ATG预处理的完全缓解急性髓系白血病移植患者中,单倍体家族移植表现出更强的供受者同种异体反应性,表现为急性GVHD增加和完全供者嵌合可能性更高。

研究设计与样本

  • 前瞻性、探索性、单中心研究,纳入101例完全缓解的急性髓系白血病患者,接受统一含抗胸腺细胞球蛋白的预处理方案后行异基因造血细胞移植,比较单倍体家族供者、同胞全合供者和无关供者三组结局。

主要发现

  • 急性GVHD累积发生率单倍体家族移植49%、同胞全合移植7%、无关供者移植16%(p<0.001)。
  • 单倍体家族移植中观察到的急性GVHD有四分之一发生于植入后3天内,特征为弥漫性皮疹、发热、体重增加和低白蛋白血症;同胞全合移植或无关供者移植患者中未观察到这种围植入期急性GVHD。
  • 移植后1个月外周血单个核细胞完全供者嵌合比例单倍体家族移植88%、同胞全合移植46%、无关供者移植69%(p=0.001)。
  • 植入、慢性GVHD、白血病复发、非复发死亡和患者生存方面无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In a prospective, explorative study, the donor-source difference of haploidentical family (HF), matched sibling (MS), and unrelated donors (UD) was evaluated for the outcome of haematopoietic cell transplantations (HCT) in 101 patients with acute myeloid leukaemia (AML) in complete remission (CR). To eliminate compounding effects, a uniform conditioning regimen containing antithymocyte globulin (ATG) was used. After transplantation, there was a significantly higher cumulative incidence of acute graft-versus-host disease (GVHD) in HF-HCT patients (49%, 7%, and 16% for HF-, MS- and UD-HCT respectively; p < 0.001). A quarter of acute GVHD cases observed in HF-HCT patients occurred within three days of engraftment and were characterized by diffuse skin rash, fever, weight gain, and hypoalbuminaemia. This peri-engraftment acute GVHD was not observed in MS-HCT or UD-HCT patients. Additionally, a significantly higher proportion of HF-HCT patients achieved complete donor chimaerism in the peripheral mononuclear cells at one month (88%, 46%, and 69% for HF-, MS- and UD-HCT respectively; p = 0.001). There was no significant difference in engraftment, chronic GVHD, leukaemia recurrence, non-relapse mortality, and patient survival. In patients with AML in CR who received HCT using ATG-containing conditioning, stronger donor-patient alloreactivity was observed in HF-HCT, in terms of increased acute GVHD and higher likelihood of complete donor chimaerism.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Choi Y, Choi EJ, Park HS, et al. A uniform conditioning regimen of busulfan, fludarabine, and antithymocyte globulin for allogeneic haematopoietic cell transplantation from haploidentical family, matched sibling, or unrelated donors-A single-centre, prospective, explorative study. Br J Haematol. 2022. PMID: 36370064. doi:10.1111/bjh.18550

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。